Cyanotech Corporation

CYAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $257.0K $707.0K $974.0K $2.6M $3.8M $2.4M $840.0K $1.3M
Accounts Receivable $2.0M $2.1M $1.3M $3.7M $2.4M $2.2M $2.0M $2.7M
Inventory $7.8M $7.3M $10.7M $9.5M $8.4M $9.7M $11.3M $9.0M
Total Current Assets $10.5M $10.6M $13.5M $16.3M $15.1M $14.7M $14.6M $13.6M
Property, Plant & Equipment $8.9M $10.1M $11.4M $11.9M $12.1M $13.0M $14.8M $15.7M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $23.5M $25.1M $29.7M $32.0M $30.9M $31.8M $29.6M $29.7M
Liabilities
Accounts Payable $2.2M $1.4M $1.0M $2.4M $2.3M $2.1M $4.9M $3.5M
Total Current Liabilities $10.2M $8.6M $8.1M $4.8M $5.8M $6.4M $9.5M $5.7M
Long-Term Debt $1.0M $1.0M $1.0M $4.3M $4.8M $6.0M $5.2M $156.0K
Total Liabilities $14.6M $13.3M $13.4M $12.6M $13.8M $15.9M $14.7M $11.6M
Stockholders' Equity
Retained Earnings $-26.1M $-22.9M $-17.6M $-14.2M $-16.3M $-17.3M $-17.7M $-14.1M
Total Stockholders' Equity $8.9M $11.8M $16.3M $19.5M $17.0M $15.8M $14.9M $18.1M
← Newer Page 1 of 2 Older →